Microglia in HIV-associated neurological diseases (Q34309557)

1 August 2017

1 reference

title

Microglia in HIV-associated neurological diseases (English)

1 reference

1 August 2017

0 references

Glass JD

1

1 reference

1 August 2017

Wesselingh SL

series ordinal

2

1 reference

1 August 2017

publication date

1 July 2001

1 reference

Microscopy Research and Technique

1 August 2017

published in

1 reference

1 August 2017

volume

54

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

95-105

1 reference

Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41.

1 August 2017

cites work

1 reference

Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage

21 January 2018

1 reference

Human astrocytes proliferate in response to tumor necrosis factor alpha

21 January 2018

1 reference

Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis

21 January 2018

1 reference

Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

21 January 2018

1 reference

Distribution of human immunodeficiency virus (HIV) in the CNS of children with severe HIV encephalomyelopathy

21 January 2018

1 reference

Neuropathology of Human Immunodeficiency Virus Infection

21 January 2018

1 reference

The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases

21 January 2018

1 reference

Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus

21 January 2018

1 reference

The involvement of the cerebral cortex in human immunodeficiency virus encephalopathy: a morphological and immunohistochemical study

21 January 2018

1 reference

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

21 January 2018

1 reference

Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia

21 January 2018

1 reference

Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis

21 January 2018

1 reference

Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis

21 January 2018

1 reference

Early viral brain invasion in iatrogenic human immunodeficiency virus infection

21 January 2018

1 reference

Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures

21 January 2018

1 reference

HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists

21 January 2018

1 reference

HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies

21 January 2018

1 reference

Neuronal loss in the frontal cortex in HIV infection

21 January 2018

1 reference

Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia

21 January 2018

1 reference

Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia

21 January 2018

1 reference

Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes

21 January 2018

1 reference

Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid

21 January 2018

1 reference

M-CSF production by HIV-1-infected monocytes and its intrathecal synthesis. Implications for neurological HIV-1-related disease

21 January 2018

1 reference

Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease

21 January 2018

1 reference

Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1.

21 January 2018

1 reference

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

21 January 2018

1 reference

Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia

21 January 2018

1 reference

Induction of NF-kappa B during monocyte differentiation is associated with activation of HIV-gene expression

21 January 2018

1 reference

Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome

21 January 2018

1 reference

Sustained increases in cerebrospinal fluid quinolinic acid concentrations in rhesus macaques (Macaca mulatta) naturally infected with simian retrovirus type-D.

21 January 2018

1 reference

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

21 January 2018

1 reference

A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate

21 January 2018

1 reference

Migration of Hematogenous Cells Through the Blood-Brain Barrier and the Initiation of CNS Inflammation

21 January 2018

1 reference

HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates

21 January 2018

1 reference

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome

21 January 2018

1 reference

Loss of neurons in the frontal cortex in AIDS brains

21 January 2018

1 reference

Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS).

21 January 2018

1 reference

Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains

21 January 2018

1 reference

Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature

21 January 2018

1 reference

Protein kinase regulates tumor necrosis factor mRNA stability in virus-stimulated astrocytes

21 January 2018

1 reference

HIV-related neurotoxicity

21 January 2018

1 reference

Models of neuronal injury in AIDS: another role for the NMDA receptor?

21 January 2018

1 reference

Excitatory amino acids as a final common pathway for neurologic disorders.

21 January 2018

1 reference

Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity.

21 January 2018

1 reference

Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity

21 January 2018

1 reference

Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center

21 January 2018

1 reference

Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings

21 January 2018

1 reference

Neuropathological changes in early HIV-1 dementia

21 January 2018

1 reference

The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study

21 January 2018

1 reference

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

21 January 2018

1 reference

Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages

21 January 2018

1 reference

AIDS and the brain: is there a chemokine connection?

21 January 2018

1 reference

Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism

21 January 2018

1 reference

Biology and pathogenesis of lentiviruses

21 January 2018

1 reference

Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon

21 January 2018

1 reference

The AIDS dementia complex: I. Clinical features

21 January 2018

1 reference

The AIDS dementia complex: II. Neuropathology

21 January 2018

1 reference

The release and uptake of excitatory amino acids

21 January 2018

1 reference

Cerebral atrophy in AIDS: a stereological study.

21 January 2018

1 reference

Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain

21 January 2018

1 reference

Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome

21 January 2018

1 reference

Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures

21 January 2018

1 reference

Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier

21 January 2018

1 reference

Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains

21 January 2018

1 reference

Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex

21 January 2018

1 reference

Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues

21 January 2018

1 reference

HIV-1-associated cognitive/motor complex: absence of neuronal loss in the cerebral neocortex

21 January 2018

1 reference

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

21 January 2018

1 reference

Pathology of HIV-1 infection of the central nervous system. A review

21 January 2018

1 reference

HTLV-III infection in brains of children and adults with AIDS encephalopathy

21 January 2018

1 reference

Apoptosis induced by HIV-1 infection of the central nervous system

21 January 2018

1 reference

Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry

21 January 2018

1 reference

Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice.

21 January 2018

1 reference

HIV-1 infection of subcortical astrocytes in the pediatric central nervous system

21 January 2018

1 reference

Cytokine expression in the brain during the acquired immunodeficiency syndrome

21 January 2018

1 reference

Human Astrocytes Stimulate HIV-1 Expression in a Chronically Infected Promonocyte Clone via Interleukin-6

21 January 2018

1 reference

Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome

21 January 2018

1 reference

Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia

21 January 2018

1 reference

Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry

21 January 2018

1 reference

Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome

21 January 2018

1 reference

Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients

21 January 2018

1 reference

Neocortical damage during HIV infection

21 January 2018

1 reference

Monocyte-mediated entry of pathogens into the central nervous system

21 January 2018

1 reference

Unraveling the mechanisms of neurotoxicity in HIV type 1-associated dementia: inhibition of neuronal synaptic transmission by macrophage secretory products

21 January 2018

1 reference

Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement

21 January 2018

1 reference

Brain viral burden in HIV infection.

21 January 2018

1 reference

Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging

21 January 2018

1 reference

Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study

21 January 2018

1 reference

Prostaglandin F2? levels in human cerebrospinal fluid in normal and pathological conditions

21 January 2018

1 reference

Clinical-neuropathologic correlation in HIV-associated dementia

21 January 2018

1 reference

Pathology of the central nervous system in 40 cases of acquired immune deficiency syndrome (AIDS)

21 January 2018

1 reference

The negative side of cost-effectiveness analysis

21 January 2018

1 reference

Differences among HIV-1 variants in their ability to elicit secretion of TNF-alpha

21 January 2018

1 reference

Involvement of microglia in cerebrospinal fluid glutamate increase in SIV-infected rhesus monkeys (Macaca mulatta)

21 January 2018

1 reference

Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 1. Association between amount of prostaglandin produced, natu

21 January 2018

1 reference

Cytokine patterns during the progression to AIDS

21 January 2018

1 reference

Histopathology of the central nervous system in the acquired immunodeficiency syndrome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JEMT.1124

1 reference

1 August 2017

1 reference